Mechanisms of gefitinib-induced QT prolongation

SKF-96365 blocks human ether-à-go-go-related gene potassium channels stably expressed in HEK 293 cells

(2016) Hui Liu et al.   PHARMACOLOGICAL RESEARCH

Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors

(2015) J S L Kloth et al.   BRITISH JOURNAL OF CANCER

Experimental design and analysis and their reporting: new guidance for publication in BJP

(2015) Michael J Curtis et al.   BRITISH JOURNAL OF PHARMACOLOGY

QT interval correction assessment in the anesthetized guinea pig

(2015) Pierre Morissette et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

Slow Delayed Rectifier Potassium Current Blockade Contributes Importantly to Drug-Induced Long QT Syndrome

(2013) Christiaan C. Veerman et al.   Circulation-Arrhythmia and Electrophysiology

Genotyping and Genomic Profiling of Non–Small-Cell Lung Cancer: Implications for Current and Future Therapies

(2013) Tianhong Li et al.   JOURNAL OF CLINICAL ONCOLOGY

New Targetable Oncogenes in Non–Small-Cell Lung Cancer

(2013) Geoffrey R. Oxnard et al.   JOURNAL OF CLINICAL ONCOLOGY

ALKin Lung Cancer: Past, Present, and Future

(2013) Alice T. Shaw et al.   JOURNAL OF CLINICAL ONCOLOGY

A Novel Classification of Lung Cancer into Molecular Subtypes

(2012) Lisandra West et al.   PLoS One

Decreased cardiac L-type Ca2+ channel activity induces hypertrophy and heart failure in mice

(2011) Sanjeewa A. Goonasekera et al.   JOURNAL OF CLINICAL INVESTIGATION

Electrophysiological Effects of the Anti-Cancer Drug Lapatinib on Cardiac Repolarization

(2010) Hyang-Ae Lee et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

The calmodulin inhibitor N-(6-aminohexyl)-5-chloro-1-naphthalene sulphonamide directly blocks human ether à-go-go-related gene potassium channels stably expressed in human embryonic kidney 293 cells

(2010) Xiao-Hua Zhang et al.   BRITISH JOURNAL OF PHARMACOLOGY

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Cardiotoxicity induced by tyrosine kinase inhibitors

(2009) George S. Orphanos et al.   ACTA ONCOLOGICA

The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

(2008) C.-H. Yun et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Molecular-targeted therapies: Lessons from years of clinical development

(2007) Daniela D. Rosa et al.   CANCER TREATMENT REVIEWS